We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
There have been reports of worsening nasal congestion (rebound congestion) when the effects of nasal decongestant sprays or drops containing xylometazoline hydrochloride and oxymetazoline hydrochloride, wear off.
The MHRA has limited the use of nasal decongestant sprays containing xylometazoline and oxymetazoline to a maximum of five days due to side effects of prolonged use.
Using the nasal spray flu vaccine for the UK childhood influenza immunisation programme: advice from JCVI
Information for parents on PHE’s position regarding the use of porcine gelatine in Fluenz, the children’s nasal spray flu vaccine.
We want to know what you think about our proposal to Nasonex Allergy Control Nasal Spray available without prescription.
Summary of the latest safety advice for medicines and medical device users
This report (HPA-CRCE-031) is a compilation of data on extra-thoracic (ET) retention and clearance from a human study of nasal clearance.
A review of Industrial Injuries Disablement Benefit entitlement for people with chromium and sino-nasal cancer.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).